In October 2022, the regulator issued a CRL, requesting additional information and analysis related to the infusion device and drug product across several areas of the New Drug Application (NDA)
HbA1c : The meta-analysis contained 22 randomized controlled studies with over 18,000 participants
It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction
If you are experiencing side effects that make you reluctant to continue treatment , such as persistent nausea, vomiting, or gastrointestinal discomfort, discuss these openly with your healthcare provider rather than simply missing doses
4. Apply twice to get the best results
That means more hair enters the shedding stage at once